11th Annual Managed Markets & Account Management Strategies Conference

September 18-19, 2019 | New Orleans, LA
Download Overview


“I thought the conference was excellent!  Having a conference tailored to one discipline made each panel and contact relevant.”

Director, Compliance & Legal Affairs

“Great insight to hear payer perspective in contracting and account management and the changing healthcare landscape.”

Channel Liaison

“It was definitely an excellent well-rounded opportunity to meet new people, get new ideas, and get an in-depth education on what’s to come with the FDA collaborations.”

Quality Engineer
Centurion Medical Products

“It was very well organized event and high quality, the fact to have an IVD track was also interesting. Thanks, I will recommend the Q1 event!”

Regulatory Affairs – EMEA Regional Head

“The organization and support staff were fantastic! I’m looking forward to next year.”

Global Business Project Lead

About the Conference:

Executives responsible for managed markets and payer relations within pharmaceutical and biotechnology companies face an array of challenges in developing innovative contracts with managed care organizations which focus heavily on value and outcome oriented benchmarks. With a goal of ensuring product coverage and access to treatments, the Q1 Managed Markets & Account Management Strategies brings together stakeholders from across the spectrum, including payer contracting executives, pharmacy benefit management teams as well as integrated delivery networks to ensure an opportunity for engagement and benchmarking.

Core Topics to be Addressed:

  • Innovative Contracting with Managed Care Organizations
  • Impact of Shifting Care Models on Product Access
  • Government Managed Care Coverage Changes:
    • Medicare Part B
    • Medicare Part D
    • MACRA
    • 340B Discounts
  • Impact of Co-Pay Accumulator Programs
  • Influence of Value Assessment on Formulary Decisions

Program Highlights:

  • Emphasis on Facilitated Small Group Discussions
  • Opportunities for Debate with IDNs, PBMs and Payers
  • Robust Stakeholder Engagement from Pharma Industry


75 Attendees

All attendees come directly from pharmaceutical companies

Distinguished Presenters

Speaker recruitment in process


Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices

Share This